| Announcements |
-
2020-09-02 EASL 2020 (JKB-122 in Patients with Non-alcoholic Fatty Liver: A Phrase 2 Ran...
JKB-122 in Patients with Non-alcoholic Fatty Liver: A Phrase 2 Randomized Double-Blind Placebo-Control Study -
2020-06-19 TaiwanJ Pharmaceuticals signed up an MTA with Merck healthcare KGaA (FWB：MRK...
TaiwanJ Pharmaceuticals signed up an MTA (material transfer agreement) with Enabling Technologies, Global Business Development and Alliance Management of Merck healthcare&nbs... -
2019-03-08 TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development...
HSINCHU, Taiwan, March 8, 2019 /PRNewswire/ -- TaiwanJ Pharmaceuticals has signed a US$26 million contract with Newsoara Biopharma to license out its drug candidate JKB-122... -
2019-01-22 TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug D...
HSINCHU, Taiwan, Jan. 21, 2019 /PRNewswire/ -- TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical ne... -
2018-10-24 TaiwanJ Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Stud...
TAIPEI, Taiwan, Oct. 23, 2018 /PRNewswire/ -- TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical needs,... -
2018-05-31 TaiwanJ will join 2018 BioTaiwan Exhibition
TaiwanJ will join 2018 BioTaiwan Exhibition. Our exhibit venue is at Taipei World Trade Center- Nangang Exhibition Hall 4F. We look forward to your visit. Exhibit Date: July 19th (Thu) ~July ... -
2018-04-13 The phase 2 clinical trial result of JKB-121 for NASH has been presented at I...
TaiwanJ Pharmaceuticals is pleased to announce that the phase 2 clinical trial result of its JKB-121 has been accepted by the European Association for the Study of the Liver (EASL) to be presente... -
2017-09-20 TaiwanJ Pharmaceuticals unveiled first-stage unblinding of Phase II clinical ...
TaiwanJ Pharmaceuticals is a discovery-based drug company focused on research and development of novel ‘antiinflammatory and immunomodulating’ agents with blockbuster potential. Its ... -
2017-06-08 TaiwanJ will join 2017 BioTaiwan Exhibition
TaiwanJ will join 2017 BioTaiwan Exhibition. Our exhibit venue is at Taipei World Trade Center- Nangang Exhibition Hall 4F. You will receive a gift for joining TaiwanJ Facebook’s Fan Page at exh... -
2017-03-27 TaiwanJ supports “Autoimmune Hepatitis Association (AIHA) Patient Support and...
Over the years TaiwanJ is dedicated to chronic liver disease research. To fulfill our social responsibility, we also support educational activities for patient care and treatments in liver diseas...